12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Medigene, Nordic Group sales and marketing update

Nordic's Nordic Pharma received exclusive rights to commercialize Veregen to treat genital warts in the Czech Republic, Slovakia, Poland, Hungary, Baltic countries, Georgia and the Commonwealth of Independent States (CIS). Medigene is eligible for milestones, double-digit royalties...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >